Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable

This live event will address pioneering advancements of cell therapies in select cardiovascular diseases, including in patients with CMD.
2.00 available credits
This live event will address pioneering advancements of cell therapies in select cardiovascular diseases, including in patients with CMD.
2.00 available credits
Enroll in this meeting
November 16, 2019
06:30 PM - 09:00 PM EST
The Ritz-Carlton, Philadelphia
Petite Ballroom 2nd Floor, Ten Avenue of the Arts, Philadelphia, Pennsylvania, United States
Enrollment Fee: Free
Free
  • Overview

    This innovative, town hall format will address pioneering advancements of cell therapies in select cardiovascular diseases, including coronary microvascular dysfunction (CMD).

    Participants will be provided the opportunity to engage with the expert panelists in a unique learning exchange that promises to lead to improved retention of the clinical practice strategies with the goal of measurably improving health outcomes in cardiology/interventional practice.

    This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the underlying pathophysiology of stable angina
    • Describe appropriate diagnostic studies in the assessment of stable angina
    • Describe the effectiveness and limitations of current therapies for stable angina including PCI and pharmacotherapy                  
  • Program Schedule

    6:30 PM Registration

    7:00 PM Buffet Dinner and Program Overview
    Michael Gibson, MD, Chair and Peter Stone, MD, Co-Chair

    7:05 PM Stable Angina: State of the Art
    Peter Stone, MD

    7:15 PM Microvascular Disease: Prevalence and Unmet Needs
    C. Noel Bairey Merz, MD

    7:30 PM
    Defining Refractory Angina: Epicardial and Microvascular
    Amir Lerman, MD

    7:55 PM Pioneering Advancements in Cell Therapies
    Thomas Povsic, MD

    8:15 PM The Future of Cell-Based Therapies
    Andres Zeiher, MD

    8:35 PM Experts Take!
    All Faculty

    8:50 PM Question and Answer
    All Faculty

    9:00 PM Adjourn

  • Target Audience

    This activity is designed to meet the educational needs of cardiovascular healthcare professionals including physicians, nurses, and pharmacists who manage patients with ischemic cardiovascular disease.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and Medtelligence. GLC is accredited by the ACCME to provide continuing medical education for physicians.

    Global Learning Collaborative designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Caladrius Biosciences.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jessica McGrory prior to the live event at jmcgrory@omnia-prova.com.

     

Facebook Comments

Sign up for the Medtelligence newsletters.
Comprehensive Cardiology Education.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free